OLMA - Company ID 0001750284
The table below shows Olema Pharmaceuticals, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$146.72M | -$104.35M | -$83.73M | -$82.06M | -$50.69M | -$19.87M |
| Capital expenditure | - | $159.00K | - | $363.00K | $1.57M | $56.00K |
| Investing cash flow | -$155.76M | -$93.53M | -$4.85M | $91.48M | -$275.44M | -$56.00K |
| Dividends paid | - | - | - | - |
Olema Pharmaceuticals, Inc. reported operating cash flow of -$146.72M for fiscal year 2025. That is down 40.6% from -$104.35M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$3.08M (FY 2019) to -$146.72M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $211.30M | $268.82M | $133.41M | $476.00K | $1.39M | $358.40M |